Omega Diagnostics Group PLC
04 April 2007
Omega Diagnostics Group PLC
Omega Appoints Fumouze Diagnostics as Distributor for France
Omega Diagnostics Group PLC ('Omega'), the medical diagnostics company,
announces that it has appointed Fumouze Diagnostics ('Fumouze'), part of the
Sofibel SAS group, to act as its distributor for France.
Fumouze will initially sell Omega's Syphilis test product 'IMMUTREP - TPHA' to
infectious diseases and blood bank testing laboratories throughout France.
Created in 1963 and located in Paris, Fumouze is well established and has been
active in the diagnostics sector for over 40 years. Fumouze had a turnover of 10
Million Euros in 2006 and employs 30 staff. It has a customer base of 4,200
private laboratories and 800 hospital laboratories.
Andrew Shepherd, Chief Executive of Omega said, 'This appointment strengthens
our already significant distribution network which covers in excess of 100
countries. Fumouze is a well established company with a successful field-based
sales force. This, together with the ability to promote additional products from
the Omega range, makes Fumouze an excellent partner for success in France'.
Mrs Muriel Le Guern Fellous, General Manager of Fumouze said, 'Based on our
strong presence in the clinical laboratory sector in France and our current
dedicated product lines, we are convinced that the partnership with Omega will
contribute to a better focused service to our customers. We look forward to
actively developing this new business'.
Enquiries:
Omega Diagnostics Group PLC Parkgreen Communications Ltd
Tel: 01259 763030 Paul McManus
Andrew Shepherd, Chief Executive Tel: 020 7479 7933
Kieron Harbinson, Finance Director Mob: 07980 541 893
www.omegadiagnostics.com paul.mcmanus@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange DXGDSLSGGGRX